Origin of myofibroblasts and cellular events triggering fibrosis

Kidney International

Volumn 87, Issue 2, 2015, Pages 297-307

  Mack, Matthias ^a   Yanagita, Motoko ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

end stage kidney disease; erythropoietin; fibroblast; fibrosis; kidney disease

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ACTIN; ERYTHROPOIETIN;

BONE MARROW CELL; CELL ACTIVATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CHRONIC KIDNEY DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROCYTE; HUMAN; KIDNEY FIBROSIS; MONOCYTE; MYOFIBROBLAST; NONHUMAN; PERICYTE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANEMIA; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL MOTION; DISEASE COURSE; FIBROSIS; KIDNEY; METABOLISM; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC;

ACTINS; ANEMIA; ANIMALS; CELL MOVEMENT; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; ERYTHROPOIETIN; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; MODELS, BIOLOGICAL; MYOFIBROBLASTS; PERICYTES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84961291972     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.287     Document Type: Review

References (143)

1. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684-696.
2. Bechtel W, McGoohan S, Zeisberg EM et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16: 544-550.
3. Kaissling B, Lehir M, Kriz W. Renal epithelial injury and fibrosis. Biochim Biophys Acta 2013; 1832: 931-939.
4. Sun DF, Fujigaki Y, Fujimoto T et al. Possible involvement of myofibroblasts in cellular recovery of uranyl acetate-induced acute renal failure in rats. Am J Pathol 2000; 157: 1321-1335.
5. Fujigaki Y, Muranaka Y, Sun D et al. Transient myofibroblast differentiation of interstitial fibroblastic cells relevant to tubular dilatation in uranyl acetate-induced acute renal failure in rats. Virchows Arch 2005; 446: 164-176.
6. Nagle RB, Bulger RE. Unilateral obstructive nephropathy in the rabbit. II. Late morphologic changes. Lab Invest 1978; 38: 270-278.
7. Eyden B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 2001; 25: 39-50.
8. Eyden B, Banerjee SS, Shenjere P et al. The myofibroblast and its tumours. J Clin Pathol 2009; 62: 236-249.
9. Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol 2013; 229: 298-309.
10. Hinz B, Gabbiani G. Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biol Rep 2010; 2: 78.
11. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627.
12. Boor P, Floege J. The renal (myo-)fibroblast: a heterogeneous group of cells. Nephrol Dial Transplant 2012; 27: 3027-3036.
13. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474.
14. Le Douarin NM, Teillet MA. Experimental analysis of the migration and differentiation of neuroblasts of the autonomic nervous system and of neurectodermal mesenchymal derivatives, using a biological cell marking technique. Dev Biol 1974; 41: 162-184.
15. LeBleu VS, Taduri G, O'Connell J et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19: 1047-1053.
16. Campanholle G, Ligresti G, Gharib SA et al. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol 2013; 304: C591-C603.
17. Kramann R, Dirocco DP, Humphreys BD. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. J Pathol 2013; 231: 273-289.
18. Chang HY, Chi JT, Dudoit S et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99: 12877-12882.
19. Kaissling B, Le Hir M. The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol 2008; 130: 247-262.
20. Sato Y, Yanagita M. Renal anemia: from incurable to curable. Am J Physiol Renal Physiol 2013; 305: F1239-F1248.
21. Obara N, Suzuki N, Kim K et al. Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood 2008; 111: 5223-5232.
22. Koury ST, Koury MJ, Bondurant MC et al. Quantitation of erythropoietinproducing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1989; 74: 645-651.
23. Cullen-McEwen LA, Caruana G, Bertram JF. The where, what and why of the developing renal stroma. Nephron Exp Nephrol 2005; 99: e1-e8.
24. Dressler GR. The cellular basis of kidney development. Annu Rev Cell Dev Biol 2006; 22: 509-529.
25. Le Douarin NM. The avian embryo as a model to study the development of the neural crest: a long and still ongoing story. Mech Dev 2004; 121: 1089-1102.
26. Sainio K, Nonclercq D, Saarma M et al. Neuronal characteristics in embryonic renal stroma. Int J Dev Biol 1994; 38: 77-84.
27. Sariola H, Holm K, Henke-Fahle S. Early innervation of the metanephric kidney. Development 1988; 104: 589-599.
28. Asada N, Takase M, Nakamura J et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 2011; 121: 3981-3990.
29. Suzuki N, Hirano I, Pan X et al. Erythropoietin production in neuroepithelial and neural crest cells during primitive erythropoiesis. Nat Commun 2013; 4: 2902.
30. Souma T, Yamazaki S, Moriguchi T et al. Plasticity of renal erythropoietin-producing cells governs fibrosis. J Am Soc Nephrol 2013; 24: 1599-1616.
31. Dirocco DP, Kobayashi A, Taketo MM et al. Wnt4/b-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol 2013; 24: 1399-1412.
32. Senoo H, Yoshikawa K, Morii M et al. Hepatic stellate cell (vitamin A-storing cell) and its relative-past, present and future. Cell Biol Int 2010; 34: 1247-1272.
33. Iwaisako K, Brenner DA, Kisseleva T. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 2012; 27(Suppl 2): 65-68.
34. Kisseleva T, Cong M, Paik Y et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 2012; 109: 9448-9453.
35. Kida Y, Asahina K, Inoue K et al. Characterization of vitamin A-storing cells in mouse fibrous kidneys using Cygb/STAP as a marker of activated stellate cells. Arch Histol Cytol 2007; 70: 95-106.
36. Herman IM, D'Amore PA. Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol 1985; 101: 43-52.
37. Pallone TL, Silldorff EP. Pericyte regulation of renal medullary blood flow. Exp Nephrol 2001; 9: 165-170.
38. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011; 21: 193-215.
39. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
40. Goritz C, Dias DO, Tomilin N et al. A pericyte origin of spinal cord scar tissue. Science 2011; 333: 238-242.
41. Dulauroy S, Di Carlo SE, Langa F et al. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012; 18: 1262-1270.
42. Etchevers HC, Vincent C, Le Douarin NM et al. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001; 128: 1059-1068.
43. Korn J, Christ B, Kurz H. Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J Comp Neurol 2002; 442: 78-88.
44. Heglind M, Cederberg A, Aquino J et al. Lack of the central nervous system-And neural crest-expressed forkhead gene Foxs1 affects motor function and body weight. Mol Cell Biol 2005; 25: 5616-5625.
45. Foster K, Sheridan J, Veiga-Fernandes H et al. Contribution of neural crest-derived cells in the embryonic and adult thymus. J Immunol 2008; 180: 3183-3189.
46. Muller SM, Stolt CC, Terszowski G et al. Neural crest origin of perivascular mesenchyme in the adult thymus. J Immunol 2008; 180: 5344-5351.
47. Schrimpf C, Xin C, Campanholle G et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 2012; 23: 868-883.
48. Stark K, Eckart A, Haidari S et al. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs. Nat Immunol 2013; 14: 41-51.
49. Gomez-Skarmeta JL, de la Calle-Mustienes E, Modolell J et al. Xenopus brain factor-2 controls mesoderm, forebrain and neural crest development. Mech Dev 1999; 80: 15-27.
50. Choi YJ, Chakraborty S, Nguyen V et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 2000; 31: 1491-1497.
51. Seron D, Alexopoulos E, Raftery MJ et al. Number of interstitial capillary cross-sections assessed by monoclonal antibodies: relation to interstitial damage. Nephrol Dial Transplant 1990; 5: 889-893.
52. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996; 19: 191-195.
53. Kida Y, Duffield JS. Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol 2011; 38: 467-473.
54. Mimura I, Nangaku M. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol 2010; 6: 667-678.
55. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000; 58: 2351-2366.
56. Norman JT, Fine LG. Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol 2006; 33: 989-996.
57. Prunotto M, Budd DC, Gabbiani G et al. Epithelial-mesenchymal crosstalk alteration in kidney fibrosis. J Pathol 2012; 228: 131-147.
58. Grgic I, Campanholle G, Bijol V et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 2012; 82: 172-183.
59. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010; 21: 1819-1834.
60. Yang L, Besschetnova TY, Brooks CR et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543.
61. Borges FT, Melo SA, Ozdemir BC et al. TGF-b1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol 2013; 24: 385-392.
62. Ding H, Zhou D, Hao S et al. Sonic Hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 2012; 23: 801-813.
63. Bucala R, Spiegel LA, Chesney J et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
64. Hashimoto N, Jin H, Liu T et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004; 113: 243-252.
65. Phillips RJ, Burdick MD, Hong K et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114: 438-446.
66. Kisseleva T, Uchinami H, Feirt N et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006; 45: 429-438.
67. Sakai N, Wada T, Yokoyama H et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006; 103: 14098-14103.
68. Niedermeier M, Reich B, Rodriguez Gomez M et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009; 106: 17892-17897.
69. Haudek SB, Xia Y, Huebener P et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 2006; 103: 18284-18289.
70. Mori L, Bellini A, Stacey MA et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005; 304: 81-90.
71. Broekema M, Harmsen MC, van Luyn MJ et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 2007; 18: 165-175.
72. Li J, Deane JA, Campanale NV et al. The contribution of bone marrowderived cells to the development of renal interstitial fibrosis. Stem Cells 2007; 25: 697-706.
73. Jang HS, Kim JI, Jung KJ et al. Bone marrow-derived cells play a major role in kidney fibrosis via proliferation and differentiation in the infiltrated site. Biochim Biophys Acta 2013; 1832: 817-825.
74. Roufosse C, Bou-Gharios G, Prodromidi E et al. Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J Am Soc Nephrol 2006; 17: 775-782.
75. Abe R, Donnelly SC, Peng T et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556-7562.
76. Pilling D, Fan T, Huang D et al. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009; 4: e7475.
77. Rydell-Tormanen K, Andreasson K, Hesselstrand R et al. Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis. Lab Invest 2012; 92: 917-925.
78. Sakai N, Furuichi K, Shinozaki Y et al. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum Pathol 2009; 41: 672-678.
79. Inoue T, Plieth D, Venkov CD et al. Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int 2005; 67: 2488-2493.
80. Osterreicher CH, Penz-Osterreicher M, Grivennikov SI et al. Fibroblastspecific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc Natl Acad Sci USA 2010; 108: 308-313.
81. Le Hir M, Hegyi I, Cueni-Loffing D et al. Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys. Histochem Cell Biol 2005; 123: 335-346.
82. Vaage J, Harlos JP. Collagen production by macrophages in tumour encapsulation and dormancy. Br J Cancer 1991; 63: 758-762.
83. Vaage J, Lindblad WJ. Production of collagen type I by mouse peritoneal macrophages. J Leukoc Biol 1990; 48: 274-280.
84. Schnoor M, Cullen P, Lorkowski J et al. Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J Immunol 2008; 180: 5707-5719.
85. Bertrand S, Godoy M, Semal P et al. Transdifferentiation of macrophages into fibroblasts as a result of Schistosoma mansoni infection. Int J Dev Biol 1992; 36: 179-184.
86. Kuwana M, Okazaki Y, Kodama H et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003; 74: 833-845.
87. Schmidt M, Sun G, Stacey MA et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171: 380-389.
88. Pilling D, Buckley CD, Salmon M et al. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003; 171: 5537-5546.
89. Pilling D, Gomer RH. Differentiation of circulating monocytes into fibroblast-like cells. Methods Mol Biol 2012; 904: 191-206.
90. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87: 858-870.
91. Chesney J, Metz C, Stavitsky AB et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998; 160: 419-425.
92. Yang L, Scott PG, Giuffre J et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002; 82: 1183-1192.
93. Reich B, Schmidbauer K, Rodriguez Gomez M et al. Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model. Kidney Int 2013; 84: 78-89.
94. Sakai N, Wada T, Matsushima K et al. The renin-Angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 2008; 26: 780-790.
95. Okon K, Szumera A, Kuzniewski M. Are CD34+ cells found in renal interstitial fibrosis? Am J Nephrol 2003; 23: 409-414.
96. Grimm PC, Nickerson P, Jeffery J et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-Allograft rejection. N Engl J Med 2001; 345: 93-97.
97. Tsou CL, Peters W, Si Y et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007; 117: 902-909.
98. Chen G, Lin SC, Chen J et al. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 2011; 22: 1876-1886.
99. Xia Y, Entman ML, Wang Y. Critical role of CXCL16 in hypertensive kidney injury and fibrosis. Hypertension 2013; 62: 1129-1137.
100. van Deventer HW, Wu QP, Bergstralh DT et al. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am J Pathol 2008; 173: 253-264.
101. Chu PY, Mariani J, Finch S et al. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 2010; 176: 1735-1742.
102. Ishida Y, Kimura A, Kondo T et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am J Pathol 2007; 170: 843-854.
103. Moore BB, Kolodsick JE, Thannickal VJ et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005; 166: 675-684.
104. Moore BB, Murray L, Das A et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006; 35: 175-181.
105. Sun L, Louie MC, Vannella KM et al. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol 2011; 300: L341-L353.
106. Scholten D, Reichart D, Paik YH et al. Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 2011; 179: 189-198.
107. Xu J, Lin SC, Chen J et al. CCR2 mediates the uptake of bone marrowderived fibroblast precursors in angiotensin II-induced cardiac fibrosis. Am J Physiol Heart Circ Physiol 2010; 301: H538-H547.
108. Tapmeier TT, Fearn A, Brown K et al. Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int 2010; 78: 351-362.
109. Cheever AW, Williams ME, Wynn TA et al. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egginduced hepatic fibrosis. J Immunol 1994; 153: 753-759.
110. Chiaramonte MG, Donaldson DD, Cheever AW et al. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999; 104: 777-785.
111. Pesce J, Kaviratne M, Ramalingam TR et al. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 2006; 116: 2044-2055.
112. Reiman RM, Thompson RW, Feng CG et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 2006; 74: 1471-1479.
113. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583-594.
114. Shao DD, Suresh R, Vakil V et al. Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008; 83: 1323-1333.
115. Crawford JR, Pilling D, Gomer RH. Improved serum-free culture conditions for spleen-derived murine fibrocytes. J Immunol Methods 2010; 363: 9-20.
116. Pilling D, Tucker NM, Gomer RH. Aggregated IgG inhibits the differentiation of human fibrocytes. J Leukoc Biol 2006; 79: 1242-1251.
117. Crawford JR, Pilling D, Gomer RH. FcgRI mediates serum amyloid P inhibition of fibrocyte differentiation. J Leukoc Biol 2012; 92: 699-711.
118. Castano AP, Lin SL, Surowy T et al. Serum amyloid P inhibits fibrosis through FcgR-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 2009; 1: 5ra13.
119. Pilling D, Roife D, Wang M et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 2007; 179: 4035-4044.
120. Hong KM, Belperio JA, Keane MP et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-b and peroxisome proliferator-Activated receptor g. J Biol Chem 2007; 282: 22910-22920.
121. Liptak P, Ivanyi B. Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2006; 2: 398-404.
122. Li B, Sehajpal PK, Khanna A et al. Differential regulation of transforming growth factor b and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991; 174: 1259-1262.
123. Gan Y, Reilkoff R, Peng X et al. Role of semaphorin 7a signaling in transforming growth factor b1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum 2011; 63: 2484-2494.
124. Yang J, Lin SC, Chen G et al. Adiponectin promotes monocyte-Tofibroblast transition in renal fibrosis. J Am Soc Nephrol 2013; 24: 1644-1659.
125. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
126. Greenburg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 1982; 95: 333-339.
127. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
128. Nakaya Y, Sheng G. EMT in developmental morphogenesis. Cancer Lett 2013; 341: 9-15.
129. Strutz F, Okada H, Lo CW et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405.
130. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350.
131. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGF-b1-induced epithelial-To-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968.
132. Ivanova L, Butt MJ, Matsell DG. Mesenchymal transition in kidney collecting duct epithelial cells. Am J Physiol Renal Physiol 2008; 294: F1238-F1248.
133. Koesters R, Kaissling B, Lehir M et al. Tubular overexpression of transforming growth factor-b1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177: 632-643.
134. Picard N, Baum O, Vogetseder A et al. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol 2008; 130: 141-155.
135. Zeisberg EM, Tarnavski O, Zeisberg M et al. Endothelial-To-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13: 952-961.
136. Zeisberg EM, Potenta SE, Sugimoto H et al. Fibroblasts in kidney fibrosis emerge via endothelial-To-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-2287.
137. Hashimoto N, Phan SH, Imaizumi K et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010; 43: 161-172.
138. Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 2009; 175: 1380-1388.
139. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
140. Eddy AA, Lopez-Guisa JM, Okamura DM et al. Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol 2012; 27: 1233-1247.
141. Cochrane AL, Kett MM, Samuel CS et al. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol 2005; 16: 3623-3630.
142. Sharma K, Ix JH, Mathew AV et al. Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 2011; 22: 1144-1151.
143. Li L, Zepeda-Orozco D, Black R et al. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010; 176: 1767-1778.